Propylthiouracil

Especificaciones

51-52-5Número CAS

200-103-2Número CE

6-propyl-2-sulfanylidene-1H-pyrimidin-4-oneNombre IUPAC

C7H10N2OSFórmula química

170.23 g/molPeso molecular

propylthiouracil; 51-52-5; 6-Propyl-2-thiouracil; Propacil; Prothyran; Procasil; Propycil; Prothiurone; Thiuragyl; Prothiucil; Protiural; Prothycil; Propyl-Thiorist; Propyl-Thyracil; 6-Propylthiouracil; Thyreostat II; Propythiouracil; Propilthiouracil; 6-propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one; Propyl-Thiorit; Propylthiorit; Propylthiouracile; 6-Thio-4-propyluracil; Propiltiouracilo; 4-Propyl-2-thiouracil; Propylthiouracilum; 2-Mercapto-6-propyl-4-pyrimidone; Propiltiouracile; 2-Mercapto-6-propylpyrimid-4-one; 2-Thio-6-propyl-1,3-pyrimidin-4-one; 2-Thio-4-oxo-6-propyl-1,3-pyrimidine; 2,3-Dihydro-6-propyl-2-thioxo-4(1H)-pyrimidinone; 4-Hydroxy-2-mercapto-6-propylpyrimidine; PROPYL THIOURACIL; 2-Mercapto-4-hydroxy-6-n-propylpyrimidine; 6-propyl-2-sulfanylidene-1H-pyrimidin-4-one; 6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione; DTXSID5021209; NSC-6498; 4(1H)-Pyrimidinone, 2,3-dihydro-6-propyl-2-thioxo-; NSC-70461; CHEBI:8502; 721M9407IY; DTXCID101209; NSC70461; 6-propyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidin-4-one; 6 Propyl 2 Thiouracil; RefChem:55928; H03BA02; 200-103-2; 2-Mercapto-6-propylpyrimidin-4-ol; 6-N-Propylthiouracil; 6-N-Propyl-2-thiouracil; PTU (thyreostatic); 6-Propil-tiouracile; Uracil, 6-propyl-2-thio-; MFCD00006041; 500-50-5; NSC 6498; 6-propyl-2-sulfanylpyrimidin-4-ol; 2-mercapto-6-propylpyrimidin-4(3H)-one; MLS000028494; CAS-51-52-5; 6-propyl-2-sulfanylidene-2,3-dihydropyrimidin-4(1H)-one; NCGC00022715-03; SMR000058275; Propiltiouracile [DCIT]; 6-n-Propylthiouracil;6-Propyl-2-thiouracil;PTU; WLN: T6MYMVJ BUS F3; 6-Propil-tiouracile [Italian]; Propiltiouracilo [INN-Spanish]; Propylthiouracile [INN-French]; Propylthiouracilum [INN-Latin]; 6-Propyl-2-thio-2,3H)-pyrimidinedione; CCRIS 544; HSDB 3390; SR-05000001706; 4(1H)-Pyrimidinone,3-dihydro-6-propyl-2-thioxo-; EINECS 200-103-2; 6-(n-Propyl)-2-thiouracil; AI3-25477; Propylthiouracil; 2,3-dihydro-6-propyl-2-thioxopyrimidin-4(1H)-one; UNII-721M9407IY; Propylthiouracil RS; Prestwick_810; 6-Propyl-2-thioxo-2, 3-dihydropyrimidin-4(1H)-one; Propylthiouracil CRS; Propylthiouracil [USP:INN:BAN:JAN]; 6-propyl-2-thioxo-1H-pyrimidin-4-one; Spectrum_000876; Opera_ID_530; 3CJ; Prestwick0_000494; Prestwick1_000494; Prestwick2_000494; Prestwick3_000494; Spectrum2_001302; Spectrum3_001731; Spectrum4_000492; Spectrum5_001815; 6-Propyl-2-thio-2,4(1H,3H)-pyrimidinedione; Propylthiouracil (Standard); 2-THIO-4-HYDROXY-6-N-PROPYL-PYRIMIDINE; CHEMBL1518; SCHEMBL41239; BSPBio_000387; BSPBio_003402; KBioGR_001003; KBioSS_001356; PROPYLTHIOURACIL [MI]; MLS002303010; MLS006011901; DivK1c_000268; PROPYLTHIOURACIL [INN]; PROPYLTHIOURACIL [JAN]; SPECTRUM1500515; SPBio_001363; SPBio_002308; PROPYLTHIOURACIL [HSDB]; PROPYLTHIOURACIL [IARC]; BPBio1_000427; GTPL6650; orb1224852; orb1309031; orb3140045; SCHEMBL4446870; SCHEMBL4537771; PROPYLTHIOURACIL [VANDF]; PROPYLTHIOURACIL [MART.]; SCHEMBL17375339; HMS500N10; HY-B0346R; KBio1_000268; KBio2_001356; KBio2_003924; KBio2_006492; KBio3_002622; MSK7141; NSC6498; PROPYLTHIOURACIL [USP-RS]; PROPYLTHIOURACIL [WHO-DD]; PROPYLTHIOURACIL [WHO-IP]; NINDS_000268; HMS1569D09; HMS1766D22; HMS1920L22; HMS2092E03; HMS2096D09; HMS2230B22; HMS3259M04; HMS3371D17; HMS3655J07; HMS3713D09; HMS5080B13; Pharmakon1600-01500515; HY-B0346; Propylthiouracil (JP18/USP/INN); PXB42394; Tox21_110882; Tox21_201741; Tox21_300280; 2-mercapto-6-propyl-pyrimidin-4-ol; AC8761; BDBM50133597; CCG-39240; EBC-06200; EBC-11046; EBC-46021; MFCD00052385; MSK7141-100M; NSC757302; s1988; SBB003855; STL102645; PROPYLTHIOURACIL [EP IMPURITY]; PROPYLTHIOURACIL [ORANGE BOOK]; 6-Propyl-2-sulfanyl-4-pyrimidinol #; AKOS000120319; AKOS001053246; AKOS015892537; MSK7141-1000M; Tox21_110882_1; 2-thio-4-hydroxy-6-n-propylpyrimidine; BS-3928; DB00550; NC00533; NSC-757302; PROPYLTHIOURACIL [EP MONOGRAPH]; PS-3436; 4-hydroxy-6-n-propylpyrimidine-2-thiol; IDI1_000268; PROPYLTHIOURACIL [USP MONOGRAPH]; 6-Propyl-2-thiouracil, enzyme inhibitor; NCGC00016229-01; NCGC00016229-02; NCGC00016229-03; NCGC00016229-04; NCGC00016229-05; NCGC00016229-06; NCGC00016229-07; NCGC00016229-08; NCGC00016229-09; NCGC00016229-10; NCGC00016229-11; NCGC00016229-13; NCGC00016229-14; NCGC00016229-22; NCGC00090881-01; NCGC00090881-02; NCGC00090881-03; NCGC00178089-01; NCGC00178089-02; NCGC00183321-01; NCGC00254180-01; NCGC00259290-01; NCGC00663696-01; 2-mercapto-4-hydroxy-6-propyl pyrimidine; 6-propyl-2-sulfanyl-1H-pyrimidin-4-one; AC-10795; propylthiouracil / 6-Propyl-2-thiouracil; SMR003317355; SY038617; SBI-0051497.P003; NS00000029; P0533; ST50308196; SW196944-3; EN300-35033; C07569; D00562; 6-propyl-2-sulfanyl-3,4-dihydropyrimidin-4-one; 6-Propyl-2-thiouracil, purum, >=98.0% (T); AB00052082_05; AB00052082_06; Propylthiouracil Solution in Methanol, 100ug/mL; AS-871/40901436; F463632; Propylthiouracil Solution in Methanol, 1000ug/mL; Q377342; 6-propyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone; SR-05000001706-1; SR-05000001706-2; SR-05000001706-3; 2,3-dihydro-6-propyl-2-thioxo-Pyrimidin-4(1H)-one; BRD-K48168960-001-04-4; BRD-K48168960-001-05-1; BRD-K48168960-001-08-5; BRD-K48168960-001-18-4; BRD-K48168960-001-19-2; Z56922173; F1967-1318; F2199-0035; F3097-4245; 6-Propyl-2-thiouracil, VETRANAL(TM), analytical standard; Propylthiouracil, European Pharmacopoeia (EP) Reference Standard; Propylthiouracil, United States Pharmacopeia (USP) Reference Standard; InChI=1/C7H10N2OS/c1-2-3-5-4-6(10)9-7(11)8-5/h4H,2-3H2,1H3,(H2,8,9,10,11Sinónimos